Is Agenus (AGEN) Stock Outpacing Its Medical Peers This Year?

Group 1 - Agenus (AGEN) is a stock that has returned 27% year-to-date, significantly outperforming the Medical sector, which has lost an average of 4.6% [4] - The Zacks Rank for Agenus is 2 (Buy), indicating a positive earnings outlook with a 13.3% increase in the consensus estimate for full-year earnings over the past 90 days [3] - Agenus belongs to the Medical - Biomedical and Genetics industry, which has 512 companies and is currently ranked 66 in the Zacks Industry Rank, while the industry has lost an average of 13.6% this year [5] Group 2 - Abbott (ABT) is another stock in the Medical sector that has shown positive performance with a year-to-date return of 0.3% [4] - Abbott is part of the Medical - Products industry, which consists of 82 stocks and is currently ranked 77, with the industry having moved up by 14.4% this year [5] - Both Agenus and Abbott are highlighted as stocks to watch in the Medical sector due to their solid performance [6]